In this video, Dr Willem Lybaert talks us through the key take aways of the...
The GEMINI-Hepatobiliary phase 2 study evaluated the efficacy of the...
The EMERALD-1 phase 3 study explored the combination of durvalumab,...
A recent analysis of the CodeBreaK 300 study has been conducted to investigate...
At ASCO, Dr Filip Van Herpe presented a poster investigating the prevalence and...
Prof Dr Erik Van Cutsem presented results from two pivotal studies at the...
Dr Gertjan Rasschaert introduces the AZUR- 4 trial, a randomised, open-label...
A Phase II trial at UZ Leuven investigated the novel immune checkpoint...
Presented by Prof Dr Hanny Al-Samkari & Dr Andreas Domen. At ASCO 2025, a...
Presented by Prof Dr Eric Van Cutsem & Prof Dr Jeroen Dekervel. At ASCO 2025, a...